Clinical Trial Update: Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)

View source ↗

Summary

The MASLD DPAILO-2 trial evaluating digital pathology and AI for liver outcomes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: PharmaNest, Inc | Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease | Status: COMPLETED